International Isotopes Inc.

Equities

INIS

US45972C1027

Industrial Machinery & Equipment

Delayed OTC Markets Other stock markets 10:04:27 2024-05-31 EDT			5-day change	1st Jan Change
0.038 ^USD	-1.81%		-2.56%	-5.00%

05-15	International Isotopes Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-11	An unknown buyer has entered into an Asset Purchase Agreement to acquire Unused assets in FEP business of International Isotopes Inc for $12.5 million.	CI

International Isotopes Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022

August 15, 2022 at 03:43 pm

International Isotopes Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was USD 0.272048 million compared to USD 0.181387 million a year ago.
For the six months, net income was USD 0.982997 million compared to net loss of USD 0.782539 million a year ago.

Latest news about International Isotopes Inc.

International Isotopes Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-15	CI
An unknown buyer has entered into an Asset Purchase Agreement to acquire Unused assets in FEP business of International Isotopes Inc for $12.5 million.	04-10	CI
International Isotopes Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-29	CI
International Isotopes Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
International Isotopes Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
International Isotopes Inc. Announces Executive Changes	23-07-18	CI
International Isotopes Inc. Appoints Shahe Bagerdjian to Serve as a Member of the Board	23-07-18	CI
International Isotopes Inc. acquired Nuclear lung ventilation product line from Amici Inc.	23-06-20	CI
Earnings Flash (INIS) INTERNATIONAL ISOTOPES Reports Q1 EPS $0.00	23-05-16	MT
International Isotopes Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
International Isotopes Inc. Announces Shahe Bagerdjian Appointed as President of the Company, Effective Immediately	23-05-08	CI
International Isotopes Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-06	CI
International Isotopes Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
International Isotopes Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
Tranche Update on International Isotopes Inc.'s Equity Buyback Plan announced on January 26, 2021.	22-05-16	CI
International Isotopes Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Tranche Update on International Isotopes Inc.'s Equity Buyback Plan announced on January 26, 2021.	22-03-31	CI
International Isotopes Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31	CI
Pharmalogic Idaho, LLC completed the acquisition of Certain Assets of International Isotopes Inc. from International Isotopes Inc..	22-02-17	CI
Pharmalogic Idaho, LLC entered into an Asset Purchase Agreement to acquire Certain Assets of International Isotopes Inc. from International Isotopes Inc. for $4 million.	22-02-15	CI
International Isotopes Inc.'s Equity Buyback announced on January 26, 2021 has expired.	22-01-24	CI
International Isotopes Inc. Announces Exclusive Licensing Agreement for Commercialization of Radiolabled Antibody Test for Detecting SARS CoV-2	21-12-07	CI
Tranche Update on International Isotopes Inc.'s Equity Buyback Plan announced on January 26, 2021.	21-11-12	CI
International Isotopes Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12	CI
Tranche Update on International Isotopes Inc.'s Equity Buyback Plan announced on January 26, 2021.	21-08-16	CI

Chart International Isotopes Inc.

Duration

Period

More charts

Company Profile

International Isotopes Inc. manufactures a range of nuclear medicine calibration and reference standards. Its Theranostics Products Segment includes production and distribution of Iodine-131 generic drug products and various isotopically pure radiochemicals. Its Cobalt Products segment includes management of a cobalt irradiation contract, fabrication of cobalt capsules for teletherapy or irradiation devices, and recycling of expended cobalt sources. Its Nuclear Medicine Standards segment consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. Its Fluorine Products segment is involved in the production of small-scale qualification samples of purity fluoride gas for various industrial applications, and development of laboratory and analytical processes.

Sector

Industrial Machinery & Equipment

Calendar

2024-08-13 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Testing & Measuring Equipment

	1st Jan change	Capi.
INTERNATIONAL ISOTOPES INC.	-5.00%	20.24M
SMC CORPORATION	+4.03%	31.87B
MKS INSTRUMENTS, INC.	+23.50%	8.69B
COGNEX CORPORATION	+8.90%	7.81B
BADGER METER, INC.	+24.83%	5.65B
INFICON HOLDING AG	+18.74%	3.86B
WUHAN GUIDE INFRARED CO., LTD.	-10.27%	3.83B
RENISHAW PLC	+11.79%	3.66B
HORIBA, LTD.	+13.15%	3.27B
ESCO TECHNOLOGIES INC.	-6.76%	2.78B

Testing & Measuring Equipment